MedTrace Logo

Effect of Flovent Discus vs QVAR vs Pulmicort Flexhaler on Short Term Growth

NCT01520688 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2020-11-18

Study results available
· View outcomes & findings →

Summary

Children with mild persistent asthma that have asthma symptoms once or twice a week and use a daily controller, while children with mild intermittent asthma rarely have asthma symptoms and do not use a daily controller. Inhaled corticosteroids are the standard treatment for mild peristent asthma. The purpose of this study is to measure children rate of growth while on different inhaled corticosteroids.

Conditions

Interventions

DRUG

Fluticasone, Budesonide, Beclomethasone

Fluticasone 100 mcg bid Budesonide 180 mcg bid Beclomethasone 80 mcg bid

DRUG

Fluticasone, Beclomethasone, Budesonide

Fluticasone 100mcg BID Beclomethasone 80 mcg BID Budesonide 180 mcg BID

DRUG

Budesonide, Fluticasone, Beclomethasone

Budesonide180 mcg BID Fluticasone 100 mcg Beclomethasone 80 mcg BID

DRUG

Budesonide, Beclomethasone, Fluticasone

Budesonide 180 mcg BID Beclomethasone 80mcg BID Fluticasone 100mcg BID

DRUG

Beclomethasone, Fluticasone, Budesonide

Beclomethasone 80 mcg BID Fluticasone 100mcg BID Budesonide 180 mcg BID

DRUG

Beclomethasone, Budesonide, Fluticasone

Beclomethasone 80mcg BID Budesonide 180 mcg BID Fluticasone 100mcg BID

Sponsors & Collaborators

  • West Penn Allegheny Health System

    lead OTHER

Principal Investigators

  • Deborah A Gentile, MD · Allegheny Singer Research Institute/Allegheny General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
6 Years
Max Age
11 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-02-29
Completion
2016-02-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01520688 on ClinicalTrials.gov